AlphAIAlphAI — Financial news for AI agents
prnewswire.comOCT 11 min read$AVTR

Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026

Avantor, Inc. (NYSE: AVTR) will release its Q3 2026 earnings on October 28, 2026, before market open, followed by a conference call at 8:00 a.m. ET. The webcast will be available live and as a replay for 30 days on the company's investor relations website.

Original reporting
prnewswire.com
Published Oct 1, 2026, 10:05 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 10:08 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026 — source image
Source · prnewswire.com
Decision brief

The 30-second read

$AVTRNeutralLow
01

Why it matters

The upcoming earnings release could drive volatility, but the date announcement alone offers little actionable insight.

02

Market read

The news is a routine earnings‑date announcement with limited immediate trading relevance.

03

What to watch

If Avantor hints at guidance changes in the upcoming call, the impact could be larger than typical date announcements.

Relevance 4/10Novelty 4/10Timing: pre‑market on Oct 28 2026

Background

Avantor is a life‑sciences tools provider that regularly reports quarterly results. The prior quarter's numbers were released on July 29 2026.

Company-level read

Ticker impact

$AVTRNeutralHigh confidence
Context

Avantor announced it will release its Q3 2026 earnings on Oct. 28, 2026 before the market opens.

Expected impact

minimal pressure as traders await the actual results

Evidence & confidence

Only the filing date is new; without numbers, the market is unlikely to move significantly until the earnings are released.

Market effects

Sector

None; the announcement does not affect the broader life‑sciences sector.

Regional

Limited to U.S. investors tracking Avantor.

Global

Low; only relevant to those holding or watching AVTR.

Counterpoint

What could challenge this read

Some traders may view the date announcement as a cue to position ahead of potential earnings surprise.

Key entities

  • company
    Avantor, Inc.

    Life‑sciences and advanced‑technology products supplier (NYSE: AVTR).

Read at source← All news

Related articles

SEP 17
$AVTRMed

Avantor (AVTR) Raises Guidance, Is The Stock Already Overvalued?

Avantor (AVTR) raised its full-year revenue and earnings guidance after Q2 2026 results, despite noting softness in Bioscience & Medtech Products. The stock has seen a 15.6% 30-day gain and 62.9% 90-day gain, but long-term returns remain negative. Analysts' consensus price target is $14.56, suggesting a 7% overvaluation, with targets ranging from $12.0 to $19.0. The P/S ratio is 1.6x, lower than industry and peer averages.

simplywall.st2 min
SEP 1
$BRKRHighAI 8/10

Research Tools & Consumables Stocks Q2 Highlights: Bruker (NASDAQ:BRKR)

Bruker (BRKR) reported Q2 revenue of $838.5M, up 5.2% YoY but missing estimates by 1.9%. Its stock fell 7.3% post-results. Avantor (AVTR) beat expectations with $1.69B revenue, up flat YoY, and its stock rose 17.1%. Waters (WAT) saw 113% revenue growth but mixed guidance, with its stock up 10.3%. Bio-Techne (TECH) and Danaher (DHR) also reported earnings, with TECH flat and DHR up 5.7% post-results.

tradingview.com3 min
AUG 19
$AVTRMed

Q2 Earnings Highs And Lows: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks

Avantor (AVTR) reported Q2 revenue of $1.69B, flat YoY, beating estimates by 4.9%, with stock up 8.2%. Bruker (BRKR) reported $838.5M revenue, up 5.2% YoY, missing estimates by 1.9%, with stock down 11.6%. Sotera Health (SHC) reported $321.4M revenue, up 9.2% YoY, beating estimates by 3.8%, with stock up 2.9%. Bio-Techne (TECH) reported $321.2M revenue, up 1.3% YoY, beating estimates by 2%, with stock flat.

yahoo.com3 min
AUG 8
$AVTRMedAI 8/10

Avantor Lifts 2026 Outlook Despite Profit Decline

Avantor Inc. (NYSE: AVTR) raised its full-year 2026 outlook after Q2 results beat expectations. Q2 net sales were $1.69B, up 0.5% YoY, with organic revenue down 0.4% (ex FX). Adjusted EPS was $0.21. Net income fell to $38.1M. Operating cash flow was $178.2M, free cash flow $142.8M, and $112.1M debt was repaid.

mychesco.com4 min